BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10918229)

  • 21. Prevalence and Predictors of Overweight and Obesity Among a Multiethnic Population of Pediatric Acute Lymphoblastic Leukemia Survivors: A Cross-Sectional Assessment.
    Brown AL; Lupo PJ; Danysh HE; Okcu MF; Scheurer ME; Kamdar KY
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):429-36. PubMed ID: 26989911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia.
    Veringa SJ; van Dulmen-den Broeder E; Kaspers GJ; Veening MA
    Pediatr Blood Cancer; 2012 Feb; 58(2):278-82. PubMed ID: 21793179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of age, gender and modifications of therapeutic protocols on physical development of children and adolescents after completion of therapy for acute lymphoblastic leukemia].
    Krawczuk-Rybak M; Kaliszewski J; Kitszel A
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):41-7. PubMed ID: 12831637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia.
    Krull KR; Li C; Phillips NS; Cheung YT; Brinkman TM; Wilson CL; Armstrong GT; Khan RB; Merchant TE; Sabin ND; Srivastava D; Pui CH; Robison LL; Hudson MM; Sklar CA; Chemaitilly W
    Cancer; 2019 May; 125(10):1748-1755. PubMed ID: 30690723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
    Richard MA; Brown AL; Belmont JW; Scheurer ME; Arroyo VM; Foster KL; Kern KD; Hudson MM; Leisenring WM; Okcu MF; Sapkota Y; Yasui Y; Morton LM; Chanock SJ; Robison LL; Armstrong GT; Bhatia S; Oeffinger KC; Lupo PJ; Kamdar KY
    Cancer; 2021 Jan; 127(2):310-318. PubMed ID: 33048379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity in long-term survivors of childhood acute lymphoblastic leukemia.
    Asner S; Ammann RA; Ozsahin H; Beck-Popovic M; von der Weid NX
    Pediatr Blood Cancer; 2008 Jul; 51(1):118-22. PubMed ID: 18338394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation.
    Stubberfield TG; Byrne GC; Jones TW
    J Pediatr Hematol Oncol; 1995 May; 17(2):167-71. PubMed ID: 7749768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation.
    Vandecruys E; Dhooge C; Craen M; Benoit Y; De Schepper J
    J Pediatr; 2013 Jul; 163(1):268-73. PubMed ID: 23351599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
    Garmey EG; Liu Q; Sklar CA; Meacham LR; Mertens AC; Stovall MA; Yasui Y; Robison LL; Oeffinger KC
    J Clin Oncol; 2008 Oct; 26(28):4639-45. PubMed ID: 18824710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
    Chow EJ; Friedman DL; Yasui Y; Whitton JA; Stovall M; Robison LL; Sklar CA
    J Pediatr; 2007 Apr; 150(4):370-5, 375.e1. PubMed ID: 17382112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.
    Waber DP; Tarbell NJ; Fairclough D; Atmore K; Castro R; Isquith P; Lussier F; Romero I; Carpenter PJ; Schiller M
    J Clin Oncol; 1995 Oct; 13(10):2490-6. PubMed ID: 7595698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth, puberty and obesity after treatment for leukaemia.
    Davies HA; Didcock E; Didi M; Ogilvy-Stuart A; Wales JK; Shalet SM
    Acta Paediatr Suppl; 1995 Sep; 411():45-50; discussion 51. PubMed ID: 8563069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia.
    Tonorezos ES; Vega GL; Sklar CA; Chou JF; Moskowitz CS; Mo Q; Church TS; Ross R; Janiszewski PM; Oeffinger KC
    Pediatr Blood Cancer; 2012 Jan; 58(1):31-6. PubMed ID: 21254377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late effects of childhood ALL treatment on body mass index and serum leptin levels.
    Karaman S; Ercan O; Yildiz I; Bolayirli M; Celkan T; Apak H; Ozkan A; Onal H; Canbolat A
    J Pediatr Endocrinol Metab; 2010 Jul; 23(7):669-74. PubMed ID: 20857839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia.
    Odame I; Reilly JJ; Gibson BE; Donaldson MD
    Arch Dis Child; 1994 Aug; 71(2):147-9. PubMed ID: 7944537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia.
    Birkebaek NH; Clausen N
    Arch Dis Child; 1998 Aug; 79(2):161-4. PubMed ID: 9797600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.
    Oeffinger KC; Adams-Huet B; Victor RG; Church TS; Snell PG; Dunn AL; Eshelman-Kent DA; Ross R; Janiszewski PM; Turoff AJ; Brooks S; Vega GL
    J Clin Oncol; 2009 Aug; 27(22):3698-704. PubMed ID: 19564534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.
    Caubet Fernandez M; Drouin S; Samoilenko M; Morel S; Krajinovic M; Laverdière C; Sinnett D; Levy E; Marcil V; Lefebvre G
    BMC Med Res Methodol; 2019 May; 19(1):100. PubMed ID: 31088361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.